Company: GNMSF
Filing Date: 2025-10-21
Form Type: SC TO-T
Source: 0001193125-25-244292
Chunk: 1

Company: GENMAB A/S
Filing Date: 2025-10-21
Form: SC TO-T
Chunk 1
---
 ( besloten vennootschap met beperkte aansprakelijkheid) organized under the laws of The Netherlands (“ Purchaser”) and a wholly owned subsidiary of Genmab A/S, a public limited liability company ( Aktieselskab) organized under the laws of Denmark (“ Genmab”), to purchase all of the issued and outstanding common shares, nominal value €0.09 per share (each, a “ Common Share,” and collectively, the “ Common Shares”), in the capital of Merus N.V., a public limited liability company ( naamloze vennootschap) organized under the laws of The Netherlands (“ Merus”), in exchange for an amount in cash equal to $97.00 per Common Share (such amount, the “ Offer Consideration”), less any applicable withholding taxes and without interest, upon the terms and subject to the conditions set forth in the Offer to Purchase, dated October 21, 2025 (as it may be amended or supplemented from time to time, the “ Offer to Purchase”), and in the letter of transmittal that accompanies the Offer to Purchase (the “ Letter of Transmittal,” and together with the Offer to Purchase and other related materials, as each may be amended or supplemented from time to time, the “ Offer”), copies of which are attached hereto as exhibits (a)(1)(A) and (a)(1)(B), respectively. All of the information set forth in the Offer to Purchase, including Schedule I thereto, is incorporated by reference herein in response to Items 1 through 9 and Item 11 of this Schedule TO, and is supplemented by the information specifically provided in this Schedule TO.

| Item 1. | Summary Term Sheet. |

The information set forth in the section of the Offer to Purchase entitled “Summary Term Sheet” is incorporated herein by reference.

| Item 2. | Subject Company Information. |

(a) The name of the subject company and the issuer of the securities to which this Schedule TO relates is Merus N.V., a Dutch public limited liability company ( naamloze vennootschap) organized under the laws of the Netherlands. Merus’ principal executive offices are located at Uppsalalaan 17, 3rd and 4th Floor, 3584 CT Utrecht, the Netherlands. Merus telephone number at such address is +31 30 253 8800. The information set forth in Section 8 of the Offer to Purchase entitled “